IRadimed Corporation

IRMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$84.94

+$2.48 (+3.01%)

Sep 22, 2026, 12:20 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	20.47M	21.98M	22.69M	21.2M	20.41M	19.51M	19.39M	18.33M	17.93M	17.6M	17.45M	16.5M	16.13M	15.48M	14.86M	13.41M	12.72M	12.31M	11.87M	10.91M	9.81M	9.22M
Cost of Revenue	5.31M	5.17M	5.66M	4.71M	4.45M	4.67M	4.63M	4.13M	3.92M	4.21M	4.04M	3.67M	3.94M	3.75M	3.64M	2.86M	2.58M	2.93M	2.62M	2.5M	2.48M	2.16M
Gross Profit	15.16M	16.81M	17.03M	16.49M	15.95M	14.84M	14.76M	14.19M	14.01M	13.39M	13.41M	12.84M	12.19M	11.72M	11.22M	10.54M	10.14M	9.38M	9.25M	8.41M	7.33M	7.06M
Operating Income	6.39M	7.24M	7.09M	6.83M	6.79M	5.43M	5.8M	5.79M	5.63M	4.75M	5.16M	5.91M	4.96M	4.01M	4.25M	4.13M	4.17M	3.07M	3.11M	3.09M	1.84M	1.78M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	6.89M	7.77M	7.79M	7.3M	7.33M	5.95M	6.34M	6.42M	6.27M	5.24M	5.68M	6.41M	5.3M	4.35M	4.7M	4.24M	4.18M	3.06M	3.11M	3.09M	1.86M	1.77M
Net Income	5.22M	5.82M	6.44M	5.58M	5.77M	4.69M	5.15M	5.05M	4.9M	4.14M	4.54M	5.07M	4.18M	3.41M	3.67M	3.43M	3.24M	2.49M	3.89M	2.58M	1.47M	1.39M
Selling & General & Admin	8.11M	8.62M	9.14M	8.99M	8.29M	8.79M	8.39M	7.76M	7.58M	7.82M	7.6M	6.48M	6.26M	6.92M	6.36M	5.92M	5.31M	5.79M	5.65M	4.84M	5.03M	4.81M
Research & Development	657K	956K	799K	674.36K	877.36K	624.25K	569.99K	639.47K	801.13K	821K	650.44K	452.56K	961.95K	793.72K	604.74K	491.64K	662.6K	519.1K	494.85K	480.7K	453.68K	475.82K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	8.77M	9.58M	9.94M	9.66M	9.17M	9.41M	8.96M	8.4M	8.38M	8.64M	8.25M	6.93M	7.22M	7.71M	6.97M	6.41M	5.97M	6.3M	6.14M	5.32M	5.49M	5.29M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	4.25M	4.05M	4.6M	4.63M	4.01M	4.18M	4.52M	3.8M	3.48M	3.83M	3.33M	2.86M	2.95M	3M	3.67M	3.04M	2.91M	3.07M	3.12M	2.59M	2.47M	2.38M
Cost & Expenses	14.08M	14.74M	15.6M	14.37M	13.62M	14.08M	13.59M	12.54M	12.3M	12.85M	12.29M	10.6M	11.17M	11.47M	10.61M	9.27M	8.55M	9.24M	8.76M	7.82M	7.97M	7.45M
Income Tax Expense	1.67M	1.95M	1.35M	1.72M	1.55M	1.26M	1.2M	1.37M	1.37M	1.11M	1.14M	1.34M	1.12M	943.59K	1.03M	810.38K	938.63K	573.3K	-779.17K	517.77K	387.73K	384.49K
Shares Outstanding (Basic)	12.78M	12.78M	12.74M	12.72M	12.72M	12.71M	12.68M	12.67M	12.66M	12.66M	12.62M	12.6M	12.6M	12.59M	12.57M	12.56M	12.56M	12.55M	12.43M	12.33M	12.31M	12.31M
Shares Outstanding (Diluted)	12.87M	12.87M	12.88M	12.86M	12.83M	12.83M	12.78M	12.78M	12.76M	12.75M	12.74M	12.74M	12.72M	12.69M	12.63M	12.63M	12.63M	12.66M	12.63M	12.6M	12.55M	12.52M
EPS (Basic)	0.40	0.46	0.51	0.44	0.45	0.37	0.41	0.40	0.39	0.33	0.36	0.40	0.33	0.27	0.29	0.27	0.26	0.20	0.31	0.21	0.12	0.11
EPS (Diluted)	0.41	0.45	0.50	0.43	0.45	0.37	0.40	0.40	0.38	0.32	0.36	0.40	0.33	0.27	0.29	0.27	0.26	0.20	0.31	0.20	0.12	0.11
EBITDA	6.39M	8.22M	8.41M	7.68M	7.92M	6.14M	6.54M	6.62M	6.47M	5.47M	5.89M	6.6M	5.49M	4.19M	4.01M	4.67M	4.67M	3.49M	3.5M	3.43M	2.21M	2.11M
EBIT	n/a	7.77M	7.79M	7.3M	7.33M	5.95M	6.34M	6.42M	6.27M	5.24M	5.68M	6.41M	5.3M	4.01M	4.7M	4.24M	4.18M	3.06M	3.11M	3.09M	1.86M	1.78M
Depreciation & Amortization	-455K	455K	614K	383.72K	592.45K	194.12K	194.87K	197.57K	199.13K	226.09K	205.38K	189.9K	187.36K	182.55K	-692.91K	435.48K	494.18K	433.93K	386.6K	340.13K	348.3K	331.79K